title: Gemfibrozil hepatotoxicity: a case report.
abstract: METHODS
  A 55-year-old woman was admitted to our hospital for management of thoracic trauma and bone fractures. One month after admission she started to receive gemfibrozil for hypertriglyceridemia. In the second month of admission, the patient complained of nausea and malaise. Laboratory value showed an acute hepatitis with raised AST, ALT. The abdominal ultrasound scan was normal, and viral serologic tests were negative. Gemfibrozil was discontinued and in a few days AST and ALT levels returned to normal.
  
  
  CONCLUSIONS
  Gemfibrozil-induced hepatitis is a rare event but should be considered in the differential diagnoses of hepatitis in which no other obvious alternative cause is found.
authors: Hospital Asepeyo Sant Cugat del Vallés, Barcelona, Spain. patriziadominguez@gmail.com
authors: Patricia
authors: P
authors: Domínguez Tordera
authors: José Francisco
authors: JF
authors: Comellas Alabern
authors: Félix
authors: F
authors: Ronda Rivero
mesh_terms: D056486:Chemical and Drug Induced Liver Injury / Q000378:metabolism*; D005260:Female; D015248:Gemfibrozil / Q000009:adverse effects*; D006801:Humans; D008111:Liver Function Tests / Q000706:statistics & numerical data; D008875:Middle Aged
chemical_list: D015248:Gemfibrozil